• 作者：Paula Á ; lvarez-Castro^a ; Susana Sangiao-Alvarellos^b ; ^c ; Iria Brandó ; n-Sandá ; ^b ; Fernando Cordido^b ; ^c ; ^{Fernando.Cordido.Carballido@sergas.es}
• 关键词：Endocrinologia ; Hormonas ; Obesidad
• 刊名：Endocrinolog¨ªa y Nutrici¨®n
• 出版年：2011
• 出版时间：October 2011
• 年：2011
• 卷：58
• 期：8
• 页码：422-432
• 全文大小：398 K

Obesity is associated to significant disturbances in endocrine function. Hyper insulinemia and insulin resistance are the best known changes in obesity, but their mechanisms and clinical significance are not clearly established. Adipose tissue is considered to be a hormone-secreting endocrine organ; and increased leptin secretion from the adipocyte, a satiety signal, is a well-established endocrine change in obesity. In obesity there is a decreased GH secretion. Impairment of somatotropic function in obesity is functional and may be reversed in certain circumstances. The pathophysiological mechanism responsible for low GH secretion in obesity is probably multifactorial. There are many data suggesting that a chronic state of somatostatin hypersecretion results in inhibition of GH release. Increased FFA levels, as well as a deficient ghrelin secretion, probably contribute to the impaired GH secretion. In women, abdominal obesity is associated to hyperandrogenism and low sex hormone-binding globulin levels. Obese men, particularly those with morbid obesity, have decreased testosterone and gonadotropin levels. Obesity is associated to an increased cortisol production rate, which is compensated for by a higher cortisol clearance, resulting in plasma free cortisol levels that do not change when body weight increases. Ghrelin is the only known circulating orexigenic factor, and has been found to be decreased in obese people. In obesity there is also a trend to increased TSH and free T3 levels.